Latest Insider Transactions at Ngm Biopharmaceuticals Inc (NGM)
This section provides a real-time view of insider transactions for Ngm Biopharmaceuticals Inc (NGM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of NGM BIOPHARMACEUTICALS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of NGM BIOPHARMACEUTICALS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 12
2022
|
David V Goeddel Director |
BUY
Open market or private purchase
|
Indirect |
83,175
+3.43%
|
$914,925
$11.72 P/Share
|
|
May 12
2022
|
Column Group L P Director |
BUY
Open market or private purchase
|
Indirect |
166,350
+3.43%
|
$1,829,850
$11.72 P/Share
|
|
May 11
2022
|
David V Goeddel Director |
BUY
Open market or private purchase
|
Indirect |
83,175
+3.7%
|
$914,925
$11.54 P/Share
|
|
May 11
2022
|
Column Group L P Director |
BUY
Open market or private purchase
|
Indirect |
166,350
+3.7%
|
$1,829,850
$11.54 P/Share
|
|
May 10
2022
|
David V Goeddel Director |
BUY
Open market or private purchase
|
Indirect |
31,265
+3.14%
|
$343,915
$11.36 P/Share
|
|
May 10
2022
|
Column Group L P Director |
BUY
Open market or private purchase
|
Indirect |
62,530
+3.14%
|
$687,830
$11.36 P/Share
|
|
May 09
2022
|
David V Goeddel Director |
BUY
Open market or private purchase
|
Indirect |
83,175
+8.19%
|
$831,750
$10.79 P/Share
|
|
May 09
2022
|
Column Group L P Director |
BUY
Open market or private purchase
|
Indirect |
166,350
+8.19%
|
$1,663,500
$10.79 P/Share
|
|
Jan 25
2022
|
David V Goeddel Director |
BUY
Open market or private purchase
|
Indirect |
599,701
+41.38%
|
-
|
|
Jan 25
2022
|
Column Group L P Director |
BUY
Open market or private purchase
|
Indirect |
1,199,402
+41.38%
|
-
|
|
Jan 24
2022
|
David V Goeddel Director |
BUY
Open market or private purchase
|
Indirect |
250,000
+50.0%
|
-
|
|
Jan 24
2022
|
Column Group L P Director |
BUY
Open market or private purchase
|
Indirect |
500,000
+50.0%
|
-
|
|
Dec 29
2021
|
David J Woodhouse Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,654
+35.45%
|
$123,578
$7.92 P/Share
|
|
Dec 07
2021
|
Jin Long Chen Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
15,000
-1.62%
|
$270,000
$18.6 P/Share
|
|
Dec 06
2021
|
Jin Long Chen Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
69,444
+6.99%
|
$69,444
$1.44 P/Share
|
|
Dec 06
2021
|
Jin Long Chen Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
15,000
-1.73%
|
$270,000
$18.21 P/Share
|
|
Nov 18
2021
|
David J Woodhouse Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
15,000
-100.0%
|
$300,000
$20.02 P/Share
|
|
Nov 18
2021
|
David J Woodhouse Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$105,000
$7.54 P/Share
|
|
Nov 15
2021
|
Jin Long Chen Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
30,000
-1.68%
|
$570,000
$19.72 P/Share
|
|
Oct 12
2021
|
Jin Long Chen Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
15,000
-1.64%
|
$300,000
$20.14 P/Share
|
|
Oct 11
2021
|
Jin Long Chen Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
15,000
-1.61%
|
$300,000
$20.41 P/Share
|
|
Oct 05
2021
|
Hsiao D Lieu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,000
-100.0%
|
$44,000
$22.0 P/Share
|
|
Oct 05
2021
|
Hsiao D Lieu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$24,000
$12.06 P/Share
|
|
Sep 14
2021
|
Jin Long Chen Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
15,000
-0.8%
|
$375,000
$25.84 P/Share
|
|
Sep 13
2021
|
Jin Long Chen Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
15,000
-0.52%
|
$390,000
$26.25 P/Share
|
|
Aug 12
2021
|
Hsiao D Lieu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
8,000
-100.0%
|
$184,000
$23.5 P/Share
|
|
Aug 12
2021
|
Hsiao D Lieu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+50.0%
|
$96,000
$12.06 P/Share
|
|
Aug 11
2021
|
Hsiao D Lieu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,258
-100.0%
|
$51,934
$23.0 P/Share
|
|
Aug 10
2021
|
Jin Long Chen Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
15,000
-1.54%
|
$345,000
$23.15 P/Share
|
|
Aug 09
2021
|
Jin Long Chen Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
15,000
-0.51%
|
$360,000
$24.85 P/Share
|
|
Jun 03
2021
|
Jin Long Chen Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
69,444
+6.56%
|
$69,444
$1.44 P/Share
|
|
May 03
2021
|
Jin Long Chen Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
25,000
-2.65%
|
$675,000
$27.62 P/Share
|
|
Apr 12
2021
|
Jin Long Chen Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
25,000
-2.58%
|
$600,000
$24.65 P/Share
|
|
Mar 01
2021
|
Jin Long Chen Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
25,000
-2.51%
|
$650,000
$26.66 P/Share
|
|
Feb 16
2021
|
Jin Long Chen Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
25,000
-2.45%
|
$700,000
$28.75 P/Share
|
|
Jan 05
2021
|
Jin Long Chen Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
150,000
+12.82%
|
$0
$0.6 P/Share
|
|
Jan 04
2021
|
Jin Long Chen Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
25,000
-1.4%
|
$725,000
$29.77 P/Share
|
|
Dec 14
2020
|
Jin Long Chen Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
25,000
-0.91%
|
$700,000
$28.22 P/Share
|
|
Nov 02
2020
|
Jin Long Chen Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
25,000
-2.65%
|
$425,000
$17.7 P/Share
|
|
Oct 12
2020
|
Jin Long Chen Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
25,000
-2.58%
|
$425,000
$17.02 P/Share
|
|
Sep 02
2020
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
27,595
+1.49%
|
$469,115
$17.67 P/Share
|
|
Sep 01
2020
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
36,494
+1.99%
|
$620,398
$17.64 P/Share
|
|
Aug 28
2020
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
26,135
+1.46%
|
$444,295
$17.89 P/Share
|
|
Aug 27
2020
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
36,359
+2.05%
|
$618,103
$17.79 P/Share
|
|
Aug 25
2020
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
100
+0.01%
|
$1,800
$18.0 P/Share
|
|
Aug 24
2020
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
11,024
+0.64%
|
$187,408
$17.96 P/Share
|
|
Aug 21
2020
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
7,321
+0.43%
|
$124,457
$17.97 P/Share
|
|
Aug 17
2020
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
6,425
+0.38%
|
$109,225
$17.89 P/Share
|
|
Aug 14
2020
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
37,993
+2.22%
|
$645,881
$17.49 P/Share
|
|
Aug 13
2020
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
19,895
+1.2%
|
$338,215
$17.89 P/Share
|